Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression

The tumorigenic mechanism for pancreatic ductal adenocarcinoma (PDAC) is not clear, although chronic inflammation is implicated. Here, we identified an inflammatory cytokine-regulated transfer RNA-derived (tRNA-derived) fragment, tRF-21-VBY9PYKHD (tRF-21), as a tumor suppressor in PDAC progression....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2021-11, Vol.131 (22), p.1-17
Hauptverfasser: Pan, Ling, Huang, Xudong, Liu, Ze-Xian, Ye, Ying, Li, Rui, Zhang, Jialiang, Wu, Guandi, Bai, Ruihong, Zhuang, Lisha, Wei, Lusheng, Li, Mei, Zheng, Yanfen, Su, Jiachun, Deng, Junge, Deng, Shuang, Zeng, Lingxing, Zhang, Shaoping, Wu, Chen, Che, Xu, Wang, Chengfeng, Chen, Rufu, Lin, Dongxin, Zheng, Jian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 17
container_issue 22
container_start_page 1
container_title The Journal of clinical investigation
container_volume 131
creator Pan, Ling
Huang, Xudong
Liu, Ze-Xian
Ye, Ying
Li, Rui
Zhang, Jialiang
Wu, Guandi
Bai, Ruihong
Zhuang, Lisha
Wei, Lusheng
Li, Mei
Zheng, Yanfen
Su, Jiachun
Deng, Junge
Deng, Shuang
Zeng, Lingxing
Zhang, Shaoping
Wu, Chen
Che, Xu
Wang, Chengfeng
Chen, Rufu
Lin, Dongxin
Zheng, Jian
description The tumorigenic mechanism for pancreatic ductal adenocarcinoma (PDAC) is not clear, although chronic inflammation is implicated. Here, we identified an inflammatory cytokine-regulated transfer RNA-derived (tRNA-derived) fragment, tRF-21-VBY9PYKHD (tRF-21), as a tumor suppressor in PDAC progression. We found that the biogenesis of tRF-21 could be inhibited by leukemia inhibitory factor and IL-6 via the splicing factor SRSF5. Reduced tRF-21 promoted AKT2/1-mediated heterogeneous nuclear ribonucleoprotein L (hnRNP L) phosphorylation, enhancing hnRNP L to interact with dead-box helicase 17 (DDX17) to form an alternative splicing complex. The provoked hnRNP L-DDX17 activity preferentially spliced Caspase 9 and mH2A1 pre-mRNAs to form Caspase 9b and mH2A1.2, promoting PDAC cell malignant phenotypes. The tRF-21 levels were significantly lower in PDACs than in normal tissues, and patients with low tRF-21 levels had a poor prognosis. Treatment of mouse PDAC xenografts or patient-derived xenografts (PDXs) with tRF-21 mimics repressed tumor growth and metastasis. These results demonstrate that tRF-21 has a tumor-suppressive effect and is a potential therapeutic agent for PDAC.
doi_str_mv 10.1172/JCI148130
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8592549</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A685496859</galeid><sourcerecordid>A685496859</sourcerecordid><originalsourceid>FETCH-LOGICAL-c647t-c8bf3741c07f352c12d5521abfed16f799e771f9d0dcd8f27b52e564e1446a93</originalsourceid><addsrcrecordid>eNqNklFrFDEQxxdRbK0--AVkQRB82Jpks5vsi3AcVk-KhVp8Dblksk3dTbZJtnjf3hzW8w7uQQLJZPKbfyaZKYrXGJ1jzMiHr8sVphzX6ElxipuGV5zU_OmefVK8iPEOIUxpQ58XJzVlrKOInxZp5cwgx1EmHzal2iT_0zqoAvTzIBPoMl1_W1Qagn3IGxNkP4JL2XtREVzGeZoCxAixnKRTAWSyqtSzSnIopQbnlQzKOj_Kcgq-37LWu5fFMyOHCK8e17Pi5uLTzfJLdXn1ebVcXFaqpSxViq9NzShWiJm6IQoT3TQEy7UBjVvDug4Yw6bTSCvNDWHrhkDTUsjPbGVXnxUf_8hO83oErXLiQQ5iCnaUYSO8tOLwxNlb0fsHwZuONHQr8PZRIPj7GWISd34OLqcsSIs4bhHF6B_VywGEdcZnMTXaqMSi5VknT1ut6gjVg4N8s3dgbHYf8OdH-Dw0jFYdDXh_EJCZBL9SL-cYxer79f-zVz8O2Xd77C3IId1GP8wpFzIeFVXBxxjA7H4aI7HtU7Hr08y-2S_NjvzbmPVvK07heg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2608160410</pqid></control><display><type>article</type><title>Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Pan, Ling ; Huang, Xudong ; Liu, Ze-Xian ; Ye, Ying ; Li, Rui ; Zhang, Jialiang ; Wu, Guandi ; Bai, Ruihong ; Zhuang, Lisha ; Wei, Lusheng ; Li, Mei ; Zheng, Yanfen ; Su, Jiachun ; Deng, Junge ; Deng, Shuang ; Zeng, Lingxing ; Zhang, Shaoping ; Wu, Chen ; Che, Xu ; Wang, Chengfeng ; Chen, Rufu ; Lin, Dongxin ; Zheng, Jian</creator><creatorcontrib>Pan, Ling ; Huang, Xudong ; Liu, Ze-Xian ; Ye, Ying ; Li, Rui ; Zhang, Jialiang ; Wu, Guandi ; Bai, Ruihong ; Zhuang, Lisha ; Wei, Lusheng ; Li, Mei ; Zheng, Yanfen ; Su, Jiachun ; Deng, Junge ; Deng, Shuang ; Zeng, Lingxing ; Zhang, Shaoping ; Wu, Chen ; Che, Xu ; Wang, Chengfeng ; Chen, Rufu ; Lin, Dongxin ; Zheng, Jian</creatorcontrib><description>The tumorigenic mechanism for pancreatic ductal adenocarcinoma (PDAC) is not clear, although chronic inflammation is implicated. Here, we identified an inflammatory cytokine-regulated transfer RNA-derived (tRNA-derived) fragment, tRF-21-VBY9PYKHD (tRF-21), as a tumor suppressor in PDAC progression. We found that the biogenesis of tRF-21 could be inhibited by leukemia inhibitory factor and IL-6 via the splicing factor SRSF5. Reduced tRF-21 promoted AKT2/1-mediated heterogeneous nuclear ribonucleoprotein L (hnRNP L) phosphorylation, enhancing hnRNP L to interact with dead-box helicase 17 (DDX17) to form an alternative splicing complex. The provoked hnRNP L-DDX17 activity preferentially spliced Caspase 9 and mH2A1 pre-mRNAs to form Caspase 9b and mH2A1.2, promoting PDAC cell malignant phenotypes. The tRF-21 levels were significantly lower in PDACs than in normal tissues, and patients with low tRF-21 levels had a poor prognosis. Treatment of mouse PDAC xenografts or patient-derived xenografts (PDXs) with tRF-21 mimics repressed tumor growth and metastasis. These results demonstrate that tRF-21 has a tumor-suppressive effect and is a potential therapeutic agent for PDAC.</description><identifier>ISSN: 1558-8238</identifier><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI148130</identifier><identifier>PMID: 34779408</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Adenocarcinoma ; AKT2 protein ; Alternative Splicing ; Biomedical research ; Biosynthesis ; Cancer ; Carcinoma, Pancreatic Ductal - genetics ; Carcinoma, Pancreatic Ductal - prevention &amp; control ; Care and treatment ; Caspase-9 ; Cell growth ; Cell Line, Tumor ; Cytokines ; Cytokines - physiology ; DEAD-box RNA Helicases - metabolism ; Development and progression ; Disease Progression ; DNA helicase ; Genetic aspects ; Health aspects ; Humans ; Inflammation ; Interleukin 6 ; Leukemia ; Leukemia inhibitory factor ; Medical prognosis ; Metastases ; Metastasis ; Pancreas ; Pancreatic cancer ; Pancreatic Neoplasms - genetics ; Pancreatic Neoplasms - prevention &amp; control ; Pancreatitis ; Patients ; Phenotypes ; Phosphorylation ; Proteins ; Proto-Oncogene Proteins c-akt - physiology ; Ribonucleoproteins - metabolism ; RNA, Transfer - physiology ; Serine-Arginine Splicing Factors - physiology ; Splicing factors ; Transfer RNA ; tRNA ; Tumor suppressor genes ; Tumor Suppressor Proteins ; Tumors ; Xenograft Model Antitumor Assays ; Xenografts</subject><ispartof>The Journal of clinical investigation, 2021-11, Vol.131 (22), p.1-17</ispartof><rights>COPYRIGHT 2021 American Society for Clinical Investigation</rights><rights>Copyright American Society for Clinical Investigation Nov 2021</rights><rights>2021 American Society for Clinical Investigation 2021 American Society for Clinical Investigation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c647t-c8bf3741c07f352c12d5521abfed16f799e771f9d0dcd8f27b52e564e1446a93</citedby><cites>FETCH-LOGICAL-c647t-c8bf3741c07f352c12d5521abfed16f799e771f9d0dcd8f27b52e564e1446a93</cites><orcidid>0000-0002-8445-4901 ; 0000-0002-2683-3321 ; 0000-0003-1626-6674</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592549/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592549/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34779408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Ling</creatorcontrib><creatorcontrib>Huang, Xudong</creatorcontrib><creatorcontrib>Liu, Ze-Xian</creatorcontrib><creatorcontrib>Ye, Ying</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Zhang, Jialiang</creatorcontrib><creatorcontrib>Wu, Guandi</creatorcontrib><creatorcontrib>Bai, Ruihong</creatorcontrib><creatorcontrib>Zhuang, Lisha</creatorcontrib><creatorcontrib>Wei, Lusheng</creatorcontrib><creatorcontrib>Li, Mei</creatorcontrib><creatorcontrib>Zheng, Yanfen</creatorcontrib><creatorcontrib>Su, Jiachun</creatorcontrib><creatorcontrib>Deng, Junge</creatorcontrib><creatorcontrib>Deng, Shuang</creatorcontrib><creatorcontrib>Zeng, Lingxing</creatorcontrib><creatorcontrib>Zhang, Shaoping</creatorcontrib><creatorcontrib>Wu, Chen</creatorcontrib><creatorcontrib>Che, Xu</creatorcontrib><creatorcontrib>Wang, Chengfeng</creatorcontrib><creatorcontrib>Chen, Rufu</creatorcontrib><creatorcontrib>Lin, Dongxin</creatorcontrib><creatorcontrib>Zheng, Jian</creatorcontrib><title>Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>The tumorigenic mechanism for pancreatic ductal adenocarcinoma (PDAC) is not clear, although chronic inflammation is implicated. Here, we identified an inflammatory cytokine-regulated transfer RNA-derived (tRNA-derived) fragment, tRF-21-VBY9PYKHD (tRF-21), as a tumor suppressor in PDAC progression. We found that the biogenesis of tRF-21 could be inhibited by leukemia inhibitory factor and IL-6 via the splicing factor SRSF5. Reduced tRF-21 promoted AKT2/1-mediated heterogeneous nuclear ribonucleoprotein L (hnRNP L) phosphorylation, enhancing hnRNP L to interact with dead-box helicase 17 (DDX17) to form an alternative splicing complex. The provoked hnRNP L-DDX17 activity preferentially spliced Caspase 9 and mH2A1 pre-mRNAs to form Caspase 9b and mH2A1.2, promoting PDAC cell malignant phenotypes. The tRF-21 levels were significantly lower in PDACs than in normal tissues, and patients with low tRF-21 levels had a poor prognosis. Treatment of mouse PDAC xenografts or patient-derived xenografts (PDXs) with tRF-21 mimics repressed tumor growth and metastasis. These results demonstrate that tRF-21 has a tumor-suppressive effect and is a potential therapeutic agent for PDAC.</description><subject>Adenocarcinoma</subject><subject>AKT2 protein</subject><subject>Alternative Splicing</subject><subject>Biomedical research</subject><subject>Biosynthesis</subject><subject>Cancer</subject><subject>Carcinoma, Pancreatic Ductal - genetics</subject><subject>Carcinoma, Pancreatic Ductal - prevention &amp; control</subject><subject>Care and treatment</subject><subject>Caspase-9</subject><subject>Cell growth</subject><subject>Cell Line, Tumor</subject><subject>Cytokines</subject><subject>Cytokines - physiology</subject><subject>DEAD-box RNA Helicases - metabolism</subject><subject>Development and progression</subject><subject>Disease Progression</subject><subject>DNA helicase</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Leukemia</subject><subject>Leukemia inhibitory factor</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Pancreas</subject><subject>Pancreatic cancer</subject><subject>Pancreatic Neoplasms - genetics</subject><subject>Pancreatic Neoplasms - prevention &amp; control</subject><subject>Pancreatitis</subject><subject>Patients</subject><subject>Phenotypes</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt - physiology</subject><subject>Ribonucleoproteins - metabolism</subject><subject>RNA, Transfer - physiology</subject><subject>Serine-Arginine Splicing Factors - physiology</subject><subject>Splicing factors</subject><subject>Transfer RNA</subject><subject>tRNA</subject><subject>Tumor suppressor genes</subject><subject>Tumor Suppressor Proteins</subject><subject>Tumors</subject><subject>Xenograft Model Antitumor Assays</subject><subject>Xenografts</subject><issn>1558-8238</issn><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNklFrFDEQxxdRbK0--AVkQRB82Jpks5vsi3AcVk-KhVp8Dblksk3dTbZJtnjf3hzW8w7uQQLJZPKbfyaZKYrXGJ1jzMiHr8sVphzX6ElxipuGV5zU_OmefVK8iPEOIUxpQ58XJzVlrKOInxZp5cwgx1EmHzal2iT_0zqoAvTzIBPoMl1_W1Qagn3IGxNkP4JL2XtREVzGeZoCxAixnKRTAWSyqtSzSnIopQbnlQzKOj_Kcgq-37LWu5fFMyOHCK8e17Pi5uLTzfJLdXn1ebVcXFaqpSxViq9NzShWiJm6IQoT3TQEy7UBjVvDug4Yw6bTSCvNDWHrhkDTUsjPbGVXnxUf_8hO83oErXLiQQ5iCnaUYSO8tOLwxNlb0fsHwZuONHQr8PZRIPj7GWISd34OLqcsSIs4bhHF6B_VywGEdcZnMTXaqMSi5VknT1ut6gjVg4N8s3dgbHYf8OdH-Dw0jFYdDXh_EJCZBL9SL-cYxer79f-zVz8O2Xd77C3IId1GP8wpFzIeFVXBxxjA7H4aI7HtU7Hr08y-2S_NjvzbmPVvK07heg</recordid><startdate>20211115</startdate><enddate>20211115</enddate><creator>Pan, Ling</creator><creator>Huang, Xudong</creator><creator>Liu, Ze-Xian</creator><creator>Ye, Ying</creator><creator>Li, Rui</creator><creator>Zhang, Jialiang</creator><creator>Wu, Guandi</creator><creator>Bai, Ruihong</creator><creator>Zhuang, Lisha</creator><creator>Wei, Lusheng</creator><creator>Li, Mei</creator><creator>Zheng, Yanfen</creator><creator>Su, Jiachun</creator><creator>Deng, Junge</creator><creator>Deng, Shuang</creator><creator>Zeng, Lingxing</creator><creator>Zhang, Shaoping</creator><creator>Wu, Chen</creator><creator>Che, Xu</creator><creator>Wang, Chengfeng</creator><creator>Chen, Rufu</creator><creator>Lin, Dongxin</creator><creator>Zheng, Jian</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8445-4901</orcidid><orcidid>https://orcid.org/0000-0002-2683-3321</orcidid><orcidid>https://orcid.org/0000-0003-1626-6674</orcidid></search><sort><creationdate>20211115</creationdate><title>Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression</title><author>Pan, Ling ; Huang, Xudong ; Liu, Ze-Xian ; Ye, Ying ; Li, Rui ; Zhang, Jialiang ; Wu, Guandi ; Bai, Ruihong ; Zhuang, Lisha ; Wei, Lusheng ; Li, Mei ; Zheng, Yanfen ; Su, Jiachun ; Deng, Junge ; Deng, Shuang ; Zeng, Lingxing ; Zhang, Shaoping ; Wu, Chen ; Che, Xu ; Wang, Chengfeng ; Chen, Rufu ; Lin, Dongxin ; Zheng, Jian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c647t-c8bf3741c07f352c12d5521abfed16f799e771f9d0dcd8f27b52e564e1446a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adenocarcinoma</topic><topic>AKT2 protein</topic><topic>Alternative Splicing</topic><topic>Biomedical research</topic><topic>Biosynthesis</topic><topic>Cancer</topic><topic>Carcinoma, Pancreatic Ductal - genetics</topic><topic>Carcinoma, Pancreatic Ductal - prevention &amp; control</topic><topic>Care and treatment</topic><topic>Caspase-9</topic><topic>Cell growth</topic><topic>Cell Line, Tumor</topic><topic>Cytokines</topic><topic>Cytokines - physiology</topic><topic>DEAD-box RNA Helicases - metabolism</topic><topic>Development and progression</topic><topic>Disease Progression</topic><topic>DNA helicase</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Leukemia</topic><topic>Leukemia inhibitory factor</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Pancreas</topic><topic>Pancreatic cancer</topic><topic>Pancreatic Neoplasms - genetics</topic><topic>Pancreatic Neoplasms - prevention &amp; control</topic><topic>Pancreatitis</topic><topic>Patients</topic><topic>Phenotypes</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt - physiology</topic><topic>Ribonucleoproteins - metabolism</topic><topic>RNA, Transfer - physiology</topic><topic>Serine-Arginine Splicing Factors - physiology</topic><topic>Splicing factors</topic><topic>Transfer RNA</topic><topic>tRNA</topic><topic>Tumor suppressor genes</topic><topic>Tumor Suppressor Proteins</topic><topic>Tumors</topic><topic>Xenograft Model Antitumor Assays</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Ling</creatorcontrib><creatorcontrib>Huang, Xudong</creatorcontrib><creatorcontrib>Liu, Ze-Xian</creatorcontrib><creatorcontrib>Ye, Ying</creatorcontrib><creatorcontrib>Li, Rui</creatorcontrib><creatorcontrib>Zhang, Jialiang</creatorcontrib><creatorcontrib>Wu, Guandi</creatorcontrib><creatorcontrib>Bai, Ruihong</creatorcontrib><creatorcontrib>Zhuang, Lisha</creatorcontrib><creatorcontrib>Wei, Lusheng</creatorcontrib><creatorcontrib>Li, Mei</creatorcontrib><creatorcontrib>Zheng, Yanfen</creatorcontrib><creatorcontrib>Su, Jiachun</creatorcontrib><creatorcontrib>Deng, Junge</creatorcontrib><creatorcontrib>Deng, Shuang</creatorcontrib><creatorcontrib>Zeng, Lingxing</creatorcontrib><creatorcontrib>Zhang, Shaoping</creatorcontrib><creatorcontrib>Wu, Chen</creatorcontrib><creatorcontrib>Che, Xu</creatorcontrib><creatorcontrib>Wang, Chengfeng</creatorcontrib><creatorcontrib>Chen, Rufu</creatorcontrib><creatorcontrib>Lin, Dongxin</creatorcontrib><creatorcontrib>Zheng, Jian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Ling</au><au>Huang, Xudong</au><au>Liu, Ze-Xian</au><au>Ye, Ying</au><au>Li, Rui</au><au>Zhang, Jialiang</au><au>Wu, Guandi</au><au>Bai, Ruihong</au><au>Zhuang, Lisha</au><au>Wei, Lusheng</au><au>Li, Mei</au><au>Zheng, Yanfen</au><au>Su, Jiachun</au><au>Deng, Junge</au><au>Deng, Shuang</au><au>Zeng, Lingxing</au><au>Zhang, Shaoping</au><au>Wu, Chen</au><au>Che, Xu</au><au>Wang, Chengfeng</au><au>Chen, Rufu</au><au>Lin, Dongxin</au><au>Zheng, Jian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2021-11-15</date><risdate>2021</risdate><volume>131</volume><issue>22</issue><spage>1</spage><epage>17</epage><pages>1-17</pages><issn>1558-8238</issn><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>The tumorigenic mechanism for pancreatic ductal adenocarcinoma (PDAC) is not clear, although chronic inflammation is implicated. Here, we identified an inflammatory cytokine-regulated transfer RNA-derived (tRNA-derived) fragment, tRF-21-VBY9PYKHD (tRF-21), as a tumor suppressor in PDAC progression. We found that the biogenesis of tRF-21 could be inhibited by leukemia inhibitory factor and IL-6 via the splicing factor SRSF5. Reduced tRF-21 promoted AKT2/1-mediated heterogeneous nuclear ribonucleoprotein L (hnRNP L) phosphorylation, enhancing hnRNP L to interact with dead-box helicase 17 (DDX17) to form an alternative splicing complex. The provoked hnRNP L-DDX17 activity preferentially spliced Caspase 9 and mH2A1 pre-mRNAs to form Caspase 9b and mH2A1.2, promoting PDAC cell malignant phenotypes. The tRF-21 levels were significantly lower in PDACs than in normal tissues, and patients with low tRF-21 levels had a poor prognosis. Treatment of mouse PDAC xenografts or patient-derived xenografts (PDXs) with tRF-21 mimics repressed tumor growth and metastasis. These results demonstrate that tRF-21 has a tumor-suppressive effect and is a potential therapeutic agent for PDAC.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>34779408</pmid><doi>10.1172/JCI148130</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0002-8445-4901</orcidid><orcidid>https://orcid.org/0000-0002-2683-3321</orcidid><orcidid>https://orcid.org/0000-0003-1626-6674</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1558-8238
ispartof The Journal of clinical investigation, 2021-11, Vol.131 (22), p.1-17
issn 1558-8238
0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8592549
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Adenocarcinoma
AKT2 protein
Alternative Splicing
Biomedical research
Biosynthesis
Cancer
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - prevention & control
Care and treatment
Caspase-9
Cell growth
Cell Line, Tumor
Cytokines
Cytokines - physiology
DEAD-box RNA Helicases - metabolism
Development and progression
Disease Progression
DNA helicase
Genetic aspects
Health aspects
Humans
Inflammation
Interleukin 6
Leukemia
Leukemia inhibitory factor
Medical prognosis
Metastases
Metastasis
Pancreas
Pancreatic cancer
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - prevention & control
Pancreatitis
Patients
Phenotypes
Phosphorylation
Proteins
Proto-Oncogene Proteins c-akt - physiology
Ribonucleoproteins - metabolism
RNA, Transfer - physiology
Serine-Arginine Splicing Factors - physiology
Splicing factors
Transfer RNA
tRNA
Tumor suppressor genes
Tumor Suppressor Proteins
Tumors
Xenograft Model Antitumor Assays
Xenografts
title Inflammatory cytokine-regulated tRNA-derived fragment tRF-21 suppresses pancreatic ductal adenocarcinoma progression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A37%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inflammatory%20cytokine-regulated%20tRNA-derived%20fragment%20tRF-21%20suppresses%20pancreatic%20ductal%20adenocarcinoma%20progression&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Pan,%20Ling&rft.date=2021-11-15&rft.volume=131&rft.issue=22&rft.spage=1&rft.epage=17&rft.pages=1-17&rft.issn=1558-8238&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI148130&rft_dat=%3Cgale_pubme%3EA685496859%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2608160410&rft_id=info:pmid/34779408&rft_galeid=A685496859&rfr_iscdi=true